Pharmafile Logo
Pharmafocus logo
Advanced Search

NHS

Showing 15 posts of 1107 posts found.

Are you reaching your customers?

January 3, 2007
Sales and Marketing NHS, healthcare, market access, marketing, strategy

The NHS is changing, and it's doing so at a rate faster than at any time in its history. Huge …

Feature
KarolSikoraWEB

The Pharmafocus Interview: Karol Sikora, Doctors for Reform

December 20, 2006
Sales and Marketing Doctors for reform, Karol Sikora, NHS

 Karol Sikora, is one of the UK’s leading cancer specialists and a high-profile exponent for radical change in the NHS. …

Feature

Are patients about to take charge?

December 18, 2006
Medical Communications, Sales and Marketing NHS, healthcare, information, patients

While debate rages about many aspects of the pharmaceutical industry, one thing is agreed: our world is becoming ever-more patient-centred. …

Feature

Is optimisation the new sales mantra?

December 11, 2006
Sales and Marketing NHS, sales, strategy

The pharmaceutical industry still refuses to fall out of love with large sales forces, but there are signs beginning to …

Feature

Can pharma help the NHS to change?

November 27, 2006
Sales and Marketing NHS, healthcare, industry relations, strategy

If there has been one constant during the 58 years of the NHS, it has been change  - continuous, relentless …

Feature

Pharma’s evolving relationship with NICE

November 1, 2006
Research and Development, Sales and Marketing NHS, NICE, approval process, fast track, healthcare

Back when New Labour was only halfway through its first term of office and when the Millennium Bug was feared …

Feature

Freedom to Prescribe v The Formulary

October 24, 2006
GP, NHS, doctors, healthcare

The modern concept of a formulary embraces three basic principles: first, it is a limited list of treatments chosen from …

Feature

Waving not drowning: tackling NHS reform

September 18, 2006
Sales and Marketing NHS, healthcare, marketing, strategy

New NHS initiatives, restructuring plans and government health policies seem to be announced and introduced on a never-ending basis, with …

Feature

Switching scripts: the impact of NHS reforms

June 15, 2006
Sales and Marketing NHS, healthcare, sales, strategy

During 2006/7, the NHS in England will see an unprecedented level of change within primary care with the reconfiguration of …

Feature

Restructure will cut costs and improve NHS services, says Hewitt

April 12, 2006
Hewitt, NHS

 Health secretary Patricia Hewitt, has unveiled a map of the new NHS ‘architecture’, which she says will reduce NHS costs …

News

Private sector vital for Government plans for patient choice

December 15, 2005
NHS, private sector

Patients are to be given more choice in their care as the NHS undertakes an ambitious set of reforms intended …

News

Industry braced for new upheaval in primary care

September 8, 2005
Sales and Marketing NHS, PCTs, Pfizer

 Likely reductions in the number of PCTs could prove disruptive to pharmaceutical companies – but the development of another NHS …

News

NHS to be key election issue as Blair unveils pledge

February 15, 2005
Blair, NHS

 Tony Blair has signalled Labour’s record on the NHS will be one of the key issues on which it will …

News

Pfizer UK recruiting for new customer-focused salesforce

July 8, 2004
NHS, Pfizer, salesforce

 Pfizer has unveiled a new, restructured UK sales team designed to meet the needs of the NHS by aligning its …

News

Takeda to launch ‘radically different’ approach to NHS

July 2, 2004
NHS, Takeda, salesforce

 Takeda UK has unveiled plans for what it calls a ‘radically different’ structure to its sales operations designed to liberate …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026